Interaction of factors related to the metabolic syndrome and vitamin d on risk of prostate cancerTUOHIMAA, Pentti; TENKANEN, Leena; SYVÄLÄ, Heimo et al.Cancer epidemiology, biomarkers & prevention. 2007, Vol 16, Num 2, pp 302-307, issn 1055-9965, 6 p.Article

Chlamydial antibodies and risk of prostate cancerANTTILA, Tarja; TENKANEN, Leena; SAIKKU, Pekka et al.Cancer epidemiology, biomarkers & prevention. 2005, Vol 14, Num 2, pp 385-389, issn 1055-9965, 5 p.Article

Circulating enterolactone and prostate cancer risk: A nordic nested case-control studySTATTIN, Pär; ADLERCREUTZ, Herman; LEHTINEN, Matti et al.International journal of cancer. 2002, Vol 99, Num 1, pp 124-129, issn 0020-7136Article

High levels of circulating testosterone are not associated with increased prostate cancer risk: A pooled prospective studySTATTIN, Pär; LUMME, Sonja; DILLNER, Joakim et al.International journal of cancer. 2004, Vol 108, Num 3, pp 418-424, issn 0020-7136, 7 p.Article